Logo image of SYENS.BR

SYENSQO SA (SYENS.BR) Stock Fundamental Analysis

Europe - EBR:SYENS - BE0974464977 - Common Stock

66.84 EUR
-0.22 (-0.33%)
Last: 10/10/2025, 9:56:32 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SYENS. SYENS was compared to 71 industry peers in the Chemicals industry. SYENS has only an average score on both its financial health and profitability. SYENS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SYENS was profitable.
In the past year SYENS had a positive cash flow from operations.
In multiple years SYENS reported negative net income over the last 5 years.
Each year in the past 5 years SYENS had a positive operating cash flow.
SYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFSYENS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of SYENS (-0.71%) is worse than 60.56% of its industry peers.
SYENS has a Return On Equity of -1.30%. This is in the lower half of the industry: SYENS underperforms 60.56% of its industry peers.
With a Return On Invested Capital value of 4.38%, SYENS perfoms like the industry average, outperforming 59.15% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SYENS is in line with the industry average of 6.85%.
The 3 year average ROIC (8.47%) for SYENS is well above the current ROIC(4.38%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROIC 4.38%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
SYENS.BR Yearly ROA, ROE, ROICSYENS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Operating Margin value of 9.25%, SYENS is doing good in the industry, outperforming 66.20% of the companies in the same industry.
SYENS's Operating Margin has declined in the last couple of years.
SYENS has a Gross Margin (31.11%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SYENS has remained more or less at the same level.
Industry RankSector Rank
OM 9.25%
PM (TTM) N/A
GM 31.11%
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
SYENS.BR Yearly Profit, Operating, Gross MarginsSYENS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SYENS is still creating some value.
The number of shares outstanding for SYENS has been reduced compared to 1 year ago.
The debt/assets ratio for SYENS has been reduced compared to a year ago.
SYENS.BR Yearly Shares OutstandingSYENS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYENS.BR Yearly Total Debt VS Total AssetsSYENS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.20 indicates that SYENS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SYENS has a Altman-Z score (2.20) which is comparable to the rest of the industry.
SYENS has a debt to FCF ratio of 25.36. This is a negative value and a sign of low solvency as SYENS would need 25.36 years to pay back of all of its debts.
SYENS has a Debt to FCF ratio of 25.36. This is comparable to the rest of the industry: SYENS outperforms 53.52% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that SYENS is not too dependend on debt financing.
SYENS has a Debt to Equity ratio (0.43) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Altman-Z 2.2
ROIC/WACC0.64
WACC6.88%
SYENS.BR Yearly LT Debt VS Equity VS FCFSYENS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

SYENS has a Current Ratio of 2.27. This indicates that SYENS is financially healthy and has no problem in meeting its short term obligations.
SYENS has a Current ratio of 2.27. This is in the better half of the industry: SYENS outperforms 73.24% of its industry peers.
SYENS has a Quick Ratio of 1.56. This is a normal value and indicates that SYENS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SYENS (1.56) is better than 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.56
SYENS.BR Yearly Current Assets VS Current LiabilitesSYENS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

2

3. Growth

3.1 Past

The earnings per share for SYENS have decreased strongly by -102.63% in the last year.
Looking at the last year, SYENS shows a decrease in Revenue. The Revenue has decreased by -3.10% in the last year.
Measured over the past years, SYENS shows a small growth in Revenue. The Revenue has been growing by 4.31% on average per year.
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%

3.2 Future

SYENS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.07% yearly.
The Revenue is expected to grow by 2.15% on average over the next years.
EPS Next Y-7.21%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
EPS Next 5Y9.07%
Revenue Next Year-2.87%
Revenue Next 2Y0.51%
Revenue Next 3Y1.82%
Revenue Next 5Y2.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SYENS.BR Yearly Revenue VS EstimatesSYENS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
SYENS.BR Yearly EPS VS EstimatesSYENS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.92, SYENS is valued on the expensive side.
64.79% of the companies in the same industry are more expensive than SYENS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.70. SYENS is valued slightly cheaper when compared to this.
SYENS is valuated reasonably with a Price/Forward Earnings ratio of 11.44.
83.10% of the companies in the same industry are more expensive than SYENS, based on the Price/Forward Earnings ratio.
SYENS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.15.
Industry RankSector Rank
PE 17.92
Fwd PE 11.44
SYENS.BR Price Earnings VS Forward Price EarningsSYENS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SYENS is valued cheaply inside the industry as 80.28% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as SYENS.
Industry RankSector Rank
P/FCF 57.4
EV/EBITDA 6.41
SYENS.BR Per share dataSYENS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.29%
EPS Next 3Y8.84%

More info and screens

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.67%, SYENS has a reasonable but not impressive dividend return.
SYENS's Dividend Yield is comparable with the industry average which is at 3.05.
Compared to the average S&P500 Dividend Yield of 2.44, SYENS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
SYENS.BR Yearly Dividends per shareSYENS.BR Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

SYENS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-210.34%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
SYENS.BR Yearly Income VS Free CF VS DividendSYENS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 500M -500M -1B

More info and screens

SYENSQO SA

EBR:SYENS (10/10/2025, 9:56:32 AM)

66.84

-0.22 (-0.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)11-06 2025-11-06
Inst Owners28.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.95B
Analysts79.29
Price Target84.05 (25.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend1.63
Dividend Growth(5Y)N/A
DP-210.34%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.92%
Min EPS beat(2)-59.05%
Max EPS beat(2)-4.8%
EPS beat(4)0
Avg EPS beat(4)-27.51%
Min EPS beat(4)-59.05%
Max EPS beat(4)-4.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.4%
Min Revenue beat(2)-4.63%
Max Revenue beat(2)-2.18%
Revenue beat(4)0
Avg Revenue beat(4)-3.18%
Min Revenue beat(4)-4.63%
Max Revenue beat(4)-1.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.19%
EPS NQ rev (1m)-3.39%
EPS NQ rev (3m)-29.03%
EPS NY rev (1m)-1.64%
EPS NY rev (3m)-13.1%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-9.14%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-4.05%
Valuation
Industry RankSector Rank
PE 17.92
Fwd PE 11.44
P/S 1.04
P/FCF 57.4
P/OCF 9.27
P/B 1.04
P/tB 2.5
EV/EBITDA 6.41
EPS(TTM)3.73
EY5.58%
EPS(NY)5.84
Fwd EY8.74%
FCF(TTM)1.16
FCFY1.74%
OCF(TTM)7.21
OCFY10.78%
SpS64.16
BVpS64.4
TBVpS26.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.71%
ROE -1.3%
ROCE 5.83%
ROIC 4.38%
ROICexc 5%
ROICexgc 8.66%
OM 9.25%
PM (TTM) N/A
GM 31.11%
FCFM 1.81%
ROA(3y)2.81%
ROA(5y)0.13%
ROE(3y)7.26%
ROE(5y)-1.97%
ROIC(3y)8.47%
ROIC(5y)7.63%
ROICexc(3y)9.08%
ROICexc(5y)8.08%
ROICexgc(3y)19%
ROICexgc(5y)18.92%
ROCE(3y)11.29%
ROCE(5y)10.17%
ROICexcg growth 3Y-19.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.3%
ROICexc growth 5YN/A
OM growth 3Y-4.48%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 25.36
Debt/EBITDA 2.11
Cap/Depr 84.98%
Cap/Sales 9.42%
Interest Coverage 250
Cash Conversion 55.24%
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.56
Altman-Z 2.2
F-Score4
WACC6.88%
ROIC/WACC0.64
Cap/Depr(3y)98.43%
Cap/Depr(5y)76.05%
Cap/Sales(3y)9.47%
Cap/Sales(5y)8.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-67.55%
EPS Next Y-7.21%
EPS Next 2Y5.29%
EPS Next 3Y8.84%
EPS Next 5Y9.07%
Revenue 1Y (TTM)-3.1%
Revenue growth 3Y4.31%
Revenue growth 5YN/A
Sales Q2Q%-7.14%
Revenue Next Year-2.87%
Revenue Next 2Y0.51%
Revenue Next 3Y1.82%
Revenue Next 5Y2.15%
EBIT growth 1Y-33.42%
EBIT growth 3Y-0.36%
EBIT growth 5YN/A
EBIT Next Year43.66%
EBIT Next 3Y19.94%
EBIT Next 5Y15.16%
FCF growth 1Y-85.81%
FCF growth 3Y-7.48%
FCF growth 5YN/A
OCF growth 1Y-52.53%
OCF growth 3Y7.55%
OCF growth 5YN/A